INDV relative valueRV
Indivior Pharmaceuticals, Inc.. How this company compares with the rest of its GICS sub-industry on the figures it reported in its last annual filing.
INDV's operating margin of 21.1% ranks in the 87th percentile of 18 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-05-31.
As of . Source: SEC EDGAR XBRL company facts. Method and limitations.
Against 21 Drug Manufacturers - Specialty & Generic peers
| Metric | INDV | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.2B USD | 567M USD | 82nd | 18 |
| Revenue YoY | n/a | -3.1% | n/a | 6 |
| Gross margin | 80.2% | 49.8% | 97th | 15 |
| Operating margin | 21.1% | -0.7% | 87th | 18 |
| Net margin | 16.9% | -5.8% | 88th | 19 |
| Return on equity | n/a | -7.5% | n/a | 17 |
| P / E | 21.9x | n/a | n/a | 3 |
| 1 year | n/a | n/a | n/a | n/a |
Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Fiscal periods ending between 2025-06-30 and 2026-05-31. Prices as of 2026-09-23. Every fundamental figure is one full fiscal year from one filing. Nothing is trailing twelve months and nothing is converted between currencies. P/E combines the market-price snapshot with annual earnings; one-year return uses market prices, dated separately above. 0001628280-26-012237
Peer set, 21 companies
RGC, KNSA, CURLF, HCM, PBH, ALVO, PRGO, ETON, GTBIF, ELAN, HROW, CRON, TLRY, VREOF, AQST, EOLS, KMDA, TKNO, NIKA, VRNO, HLN
Left out: HYPMY (no annual filing), RDY (period gap), SGIOF (no annual filing), EVO (period gap).
What could not be compared
- 30 The filer did not report this line in the filing used.
- 22 The price series does not reach back to the start of this window.
- 16 The denominator is zero or negative, so the ratio has no meaning.
- 6 This filer reports an ordinary share count and trades as a depositary receipt at a ratio Kresmion does not store, so price times shares would be wrong.
- 2 Fewer than 5 peers carry a comparable value, so no median, quartile or percentile is published.
- 2 No annual filing (10-K, 20-F or 40-F) with fiscal-year figures.
- 2 This company's fiscal year ends more than 200 days from the subject's, so it is a different economic year.
- 1 Reported in a different currency than the subject. A level in another currency is not comparable and is not converted here.
Free account
Open the relative value desk with a free account
An account turns this page into a research desk: thirty-one metrics over the whole peer set instead of eight, the distribution behind each median, the metric's history against the peer band, an editable peer set, the filing behind every cell, and CSV. The table above stays free.
Cite this data
Every fundamental figure is the full fiscal year reported on one annual SEC filing (10-K, 20-F or 40-F), named by accession. Peers are the company's GICS sub-industry. A median, quartile or percentile is published only when at least five peers carry a comparable value, and a peer reporting in another currency is excluded from a level rather than converted. P/E combines the market-price snapshot with annual earnings; one-year return uses market prices, dated separately above.
Upstream: SEC EDGAR XBRL company facts
Kresmion, "INDV relative value, Kresmion", data as of 2026-02-26, https://kresmion.com/tools/relative-value/INDV. Upstream data: SEC EDGAR XBRL company facts.